NCT05476770 2024-12-06Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Recruiting54 enrolled